Pharmaqo Labs YK11 MYOSTATIN Hybrid Sarm 60 x 5mg: Advanced Myostatin Inhibitor Research Standard

Pharmaqo Labs YK11 MYOSTATIN Hybrid Sarm 60 x 5mg delivers a specialized formulation of YK11, a unique compound classified as a selective androgen receptor modulator with distinct myostatin–inhibiting properties. This hybrid mechanism distinguishes YK11 from conventional SARMs, offering researchers a novel approach to examining muscle growth limitations and tissue development potential. Each package contains 60 capsules dosed at 5mg, providing precise administration for protocols investigating muscle wasting prevention, hypertrophy mechanisms, and strength acquisition in controlled models. The 5mg concentration enables accurate titration while the extended supply supports longitudinal studies on myostatin pathway modulation.

YK11 operates through dual mechanisms—selective androgen receptor binding combined with follistatin upregulation that inhibits myostatin activity. Myostatin naturally restricts muscle growth, acting as a biological regulator preventing excessive tissue development. By modulating this pathway, Pharmaqo Labs YK11 MYOSTATIN Hybrid Sarm 60 x 5mg allows researchers to examine the upper limits of muscle hypertrophy and the potential for overcoming genetic growth plateaus. Studies utilizing this compound investigate breakthrough applications for muscle wasting conditions, sarcopenia research, and performance optimization where traditional anabolic approaches prove insufficient.

Key Features

Hybrid Mechanism: Combines SARM activity with myostatin inhibition for enhanced anabolic potential.
Myostatin Pathway Modulation: Upregulates follistatin to overcome natural muscle growth limitations.
Precise Dosing: 5mg capsules enable accurate protocol implementation and gradual titration.
Extended Supply: 60–capsule format supports 8–12 week research protocols without interruption.
Novel Research Profile: Unique mechanism distinct from traditional androgens or standard SARMs.
Oral Bioavailability: Convenient administration with excellent absorption characteristics.
Verified Purity Standards: Manufactured under strict pharmaceutical protocols with independent batch testing.

Product Specifications

Active Ingredient: YK11 (Myostatin Inhibitor / SARM Hybrid)
Chemical Classification: Selective Androgen Receptor Modulator with Follistatin Upregulation
Dosage Strength: 5mg per capsule
Pack Size: 60 capsules
CAS Number: 1370003–76-1
Molecular Formula: C25H34O6
Appearance: White to off-white capsules
Standard Protocol: 5-10mg daily for 6-8 weeks
Storage Requirements: Store at 15°C–25°C; protect from light, moisture, and heat
Shelf Life: 3 years from manufacture date (as indicated on packaging)
Legal Status: Research chemical / Not for human consumption (Regulations vary by jurisdiction)

Mechanism of Action

Pharmaqo Labs YK11 MYOSTATIN Hybrid Sarm 60 x 5mg operates through a unique dual-pathway mechanism:

Selective AR Binding: Activates androgen receptors in skeletal muscle tissue to promote anabolic gene expression.
Follistatin Upregulation: Increases follistatin production, which binds and inhibits myostatin activity.
Myostatin Suppression: Reduces myostatin’s negative regulation on muscle growth and differentiation.
Satellite Cell Activation: Enhances muscle stem cell proliferation and fusion with existing fibers.
Protein Synthesis Enhancement: Increases translational capacity beyond normal physiological limits.
Bone Density Support: Partial activation of androgen receptors in osseous tissue.

Metabolic Impact

Research utilizing Pharmaqo Labs YK11 MYOSTATIN Hybrid Sarm 60 x 5mg reveals significant physiological effects:

Muscle Hypertrophy: Potential for gains exceeding natural genetic limitations through myostatin inhibition.
Strength Acquisition: Enhanced force production and neuromuscular efficiency.
Body Composition: Improved lean–to-fat ratios through metabolic enhancement.
Bone Mineralization: Increased density and structural integrity in skeletal tissue.
Recovery Enhancement: Accelerated repair kinetics and reduced muscle damage markers.
Endurance Capacity: Improved oxygen utilization and fatigue resistance.
Follistatin Levels: Measurable increases in circulating follistatin concentrations.

Where to Buy

Authorized Suppliers Only: Purchase exclusively from verified Pharmaqo Labs distributors with documented authorization.
Batch Verification: Verify unique batch codes through official Pharmaqo Labs channels before use.
Visual Inspection: Authentic packaging features professional labeling, intact seals, and uniform capsules free of defects.
Avoid Unverified Sources: Do not purchase from social media, underground forums, or vendors lacking proof of authenticity.

Conclusion

Pharmaqo Labs YK11 MYOSTATIN Hybrid Sarm 60 x 5mg represents a breakthrough research tool for investigators examining the myostatin pathway and its role in limiting muscle growth. The unique dual mechanism—combining traditional SARM activity with follistatin upregulation—offers unprecedented potential for studying muscle hypertrophy beyond natural genetic constraints. The precise 5mg dosing and extended 60-capsule supply support comprehensive protocols examining strength acquisition, body composition optimization, and muscle wasting prevention. Unlike conventional anabolic compounds, YK11’s ability to modulate myostatin provides insights into developmental biology and regenerative medicine applications. Researchers must exercise caution regarding the compound’s potency and relatively novel status, ensuring appropriate monitoring of liver enzymes and hormonal markers.

Reviews

There are no reviews yet.

Pharmaqo Labs YK11 MYOSTATIN Hybrid Sarm 60 x 5mg